Mycoplasma pneumoniae and Chlamydia spp. Infection in Community-Acquired Pneumonia, Germany, 2011–2012
Roger Dumke, Christiane Schnee, Mathias W. Pletz, Jan Rupp, Enno Jacobs, Konrad Sachse
1, Gernot Rohde
1
, and CAPNETZ Study Group
2
Author affiliations: Technical University Dresden Institute of Medical Microbiology and Hygiene, Dresden, Germany (R. Dumke, E. Jacobs); Friedrich-Loeffler-Institut, Jena, Germany (C. Schnee, K. Sachse); Jena University Hospital Center for Infectious Diseases and Infection Control, Jena (M.W. Pletz); CAPNETZ STIFTUNG, Hannover, Germany (M.W. Pletz, J. Rupp, G. Rohde); University of Lübeck, Lübeck, Germany (J. Rupp); Maastricht University Medical Centre, Maastricht, the Netherlands (G. Rohde)
Main Article
Table 4
Results of testing for Chlamydia spp. in 780 respiratory samples from patients with community-acquired pneumonia, Germany, 2011–2012
Species |
No. (%) positive |
C. psittaci |
17 (2.2) |
C. pneumoniae |
11 (1.4) |
C. trachomatis |
3 (0.4) |
C. suis |
2 (0.3) |
C. abortus |
1 (0.1) |
Other Chlamydia sp. |
1 (0.1) |
Simkania negevensis |
1 (0.1) |
Waddlia chondrophila
|
1 (0.1)
|
Total |
37* (4.7) |
Main Article
Page created: February 18, 2015
Page updated: February 18, 2015
Page reviewed: February 18, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.